Please check your internet connection and try again.
# Acetylcysteine
## Overview
Acetylcysteine is a mucolytic agent that decreases the viscosity of respiratory secretions. It is also an antidote for acetaminophen overdose.
## Primary Indications
* **Acetaminophen Overdose:** To prevent or reduce liver toxicity.
* **Mucolytic:** To thin and loosen mucus in patients with chronic bronchitis, emphysema, cystic fibrosis, or other bronchopulmonary diseases.
## Adult Dosing
### Acetaminophen Overdose
* **Oral:**
* **Loading Dose:** 140 mg/kg.
* **Maintenance Dose:** 70 mg/kg every 4 hours for 17 doses (total of 72 hours).
* **Intravenous (IV):**
* **Loading Dose:** 150 mg/kg infused over 60 minutes.
* **Second Infusion:** 50 mg/kg infused over 4 hours.
* **Third Infusion:** 100 mg/kg infused over 16 hours.
* *Note: IV protocols may vary; confirm local guidelines. Maximum infusion rates are crucial to avoid anaphylactoid reactions.*
### Mucolytic
* **Nebulization:** 20% solution: 6-10 mL every 3-4 hours. 10% solution: 10-20 mL every 3-4 hours.
* **Oral (effervescent tablets):** 200 mg twice daily or 200 mg three times daily.
## Pediatric Dosing
### Acetaminophen Overdose
* **Oral and Intravenous (IV):** Dosing is the same as adults (140 mg/kg loading dose, followed by 70 mg/kg every 4 hours for 17 doses orally; or 150 mg/kg over 60 min, 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours IV).
* *Note: IV protocols may vary; confirm local guidelines. Monitor for anaphylactoid reactions.*
### Mucolytic
* **Nebulization:**
* **Children < 6 years:** 10% solution: 1-2 mL every 2-6 hours.
* **Children ≥ 6 years:** 10% solution: 5-10 mL every 3-4 hours; or 20% solution: 3-5 mL every 3-4 hours.
* **Oral (effervescent tablets):** Typically not recommended for children under 2 years. Dosing for older children should be guided by product labeling or physician.
## Dose Adjustments
* **Renal or Hepatic Impairment:** No specific dose adjustments are typically required for the mucolytic indication. For acetaminophen overdose, continued vigilance for toxicity is essential regardless of hepatic function.
## Contraindications
* Known hypersensitivity to acetylcysteine.
## Adverse Effects
* **Most Common:** Nausea, vomiting, stomatitis (oral use); bronchospasm, urticaria, angioedema, pruritus, rash, rhinorrhea, drowsiness (nebulized use).
* **Anaphylactoid Reactions:** More common with IV administration, particularly during rapid infusion. Symptoms include bronchospasm, flushing, angioedema, urticaria, hypotension, and tachycardia.
## Key Drug Interactions
* **Activated Charcoal:** May adsorb oral acetylcysteine, reducing its effectiveness in acetaminophen overdose. If co-administered, consider administering acetylcysteine 1 hour after charcoal.
* **Nitroglycerin:** Increased hypotensive effect.
## Monitoring
* **Acetaminophen Overdose:** Serum acetaminophen levels, liver function tests (AST, ALT, bilirubin, INR), blood glucose, and renal function. Clinical signs of hepatotoxicity.
* **Mucolytic:** Respiratory status, sputum production, and airway patency.
## Clinical Pearls
* The odor of acetylcysteine is unpleasant and may cause nausea/vomiting.
* For IV administration in acetaminophen overdose, consider pre-treatment with an antihistamine and/or bronchodilator to mitigate anaphylactoid reactions.
* Ensure adequate hydration when used as a mucolytic.
* IV acetylcysteine should be administered through a central venous catheter if possible to minimize phlebitis.
***
Please verify current prescribing information and consult with a healthcare provider for any specific patient care decisions.